Monoxyde D‘azote Messer (Nitric Oxide)

Nitric Oxide, the active ingredient in Monoxyde D‘azote Messer, is a medical gas presented as a gas for inhalation use. It acts as a selective pulmonary vasodilator for conditions such as neonatal pulmonary hypertension, acute respiratory distress syndrome, and adult pulmonary hypertension.

GNH USA supplies Monoxyde D‘azote Messer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Monoxyde D‘azote Messer, a nitric oxide inhalation therapy, is used in pulmonary vascular disorders.

Neonatal pulmonary hypertension: reduces pulmonary arterial pressure and improves oxygenation in newborns. Acute respiratory distress syndrome: provides selective pulmonary vasodilation to enhance ventilation‑perfusion matching. Pulmonary hypertension in adults: lowers pulmonary vascular resistance and supports right‑ventricular function.

Inhaled nitric oxide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: transient mild headache. - Dizziness: occasional light‑headedness. - Cough: airway irritation leading to cough.

Serious or Rare Side Effects: - Methemoglobinemia: elevated methemoglobin reducing oxygen transport. - Nitrogen dioxide formation: pulmonary irritation from NO₂ buildup. - Rebound pulmonary hypertension: worsening pressure after sudden discontinuation.

When using inhaled nitric oxide, careful clinical monitoring and handling are essential.

Dose titration: adjust inhaled concentration under continuous monitoring of oxygenation and hemodynamics. Monitoring: regularly assess methemoglobin levels and nitrogen dioxide concentrations. Contraindications: avoid use in patients with known hypersensitivity to nitric oxide. Pregnancy: safety not established; use only if benefit outweighs risk. Interaction with methylene blue: may reduce effectiveness of methemoglobinemia treatment. Store at ambient temperature: keep cylinder in original container, protect from heat and direct sunlight.

Nitric oxide can interact with several drug classes, requiring vigilance.

Major Interactions (Avoid): - Phosphodiesterase inhibitors: additive vasodilatory effect may cause severe hypotension. - Inhaled anesthetics (e.g., nitrous oxide): synergistic pulmonary vasodilation increasing risk of systemic hypotension.

Moderate Interactions (Monitor Closely): - Anticoagulants: nitric oxide may potentiate bleeding risk. - Hemoglobin‑modifying agents (e.g., methylene blue): may interfere with methemoglobin reduction. - Inhaled bronchodilators: may alter distribution of inhaled nitric oxide.